Cargando…
Sodium Valproate Exacerbating an Underlying Disorder of Fatty Acid Metabolism
We describe a 29-year-old female who presented with rhabdomyolysis shortly after starting a course of sodium valproate. A thorough investigation revealed a likely mitochondrial origin inducing this susceptibility. An underlying mitochondrial disorder should be considered in all patients who present...
Autores principales: | Bellinge, Jamie, Herath, Sanjaya, Sonigra, Dharmesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073682/ https://www.ncbi.nlm.nih.gov/pubmed/27790123 http://dx.doi.org/10.1159/000447087 |
Ejemplares similares
-
Hypothyroidism may exacerbate valproate-related hyperammonemic delirium
por: Hung, Chung-Chieh, et al.
Publicado: (2016) -
Valproate therapy exacerbating intermediate phenotype of methylmalonic aciduria
por: Murgai, Aditya, et al.
Publicado: (2015) -
Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report
por: Mehta, Shaine, et al.
Publicado: (2018) -
Stevens - Johnson Syndrome Induced by Sodium Valproate
por: Kumar, P.N. Suresh, et al.
Publicado: (2004) -
Psoriasiform Drug Eruption Associated with Sodium Valproate
por: Gul Mert, Gulen, et al.
Publicado: (2013)